Nephrocare Healt

  • Market Cap: Small Cap
  • Industry: Healthcare Services
  • ISIN: INE428V01029
  • NSEID: NEPHROPLUS
  • BSEID: 544647
INR
549.10
-2.85 (-0.52%)
BSENSE

Apr 09

BSE+NSE Vol: 31.63 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

31.63 k (-44.24%) Volume

Shareholding (Dec 2025)

FII

9.30%

Held by 20 FIIs

DII

3.48%

Held by 9 DIIs

Promoter

63.85%

Which are the latest news on Nephrocare Healt?

09-Apr-2026
No latest news for Nephrocare Healt found.

Why is Nephrocare Health Services Ltd falling/rising?

08-Apr-2026

As of 07-Apr, Nephrocare Health Services Ltd's stock price is currently rising at 528.05, following a trend reversal after two days of decline. Despite a recent monthly decline, the stock has shown strong year-to-date performance, gaining 12.53%, and has outperformed the Sensex over the past week.

As of 07-Apr, Nephrocare Health Services Ltd's stock price is rising, currently at 528.05, reflecting a change of 2.5 (0.48%) upward. This increase follows a trend reversal after two consecutive days of decline. The stock has shown a notable performance today, reaching an intraday high of Rs 536.35, which is a 2.05% increase. <BR><BR>In the context of recent performance, the stock has outperformed the benchmark Sensex over the past week, gaining 4.45% compared to the Sensex's 3.71%. However, it has underperformed its sector by 0.38% today. Despite a decline of 5.75% over the past month, the year-to-date performance is strong, with a gain of 12.53%, contrasting with the Sensex's decline of 12.44% during the same period.<BR><BR>Investor participation appears to be declining, as evidenced by a drop in delivery volume by 8.32% against the 5-day average. Nevertheless, the stock remains liquid enough for trading, indicating that while there may be some caution among investors, the current price movement reflects a positive shift after recent declines.

View full answer

Why is Nephrocare Health Services Ltd falling/rising?

09-Apr-2026

As of 08-Apr, Nephrocare Health Services Ltd's stock price has risen to 545.15, up 3.2% due to strong buying interest and outperformance against its sector. However, a decline in investor participation may raise concerns about the sustainability of this upward trend.

As of 08-Apr, Nephrocare Health Services Ltd is experiencing a rise in its stock price, currently at 545.15, with a change of 16.9 (3.2%) upwards. This increase can be attributed to several factors. Firstly, the stock has outperformed its sector by 2.14% today and has been on a consecutive gain streak for the last two days, accumulating a total return of 3.73% during this period. Additionally, the stock opened with a significant gap up of 3.54% today and reached an intraday high of Rs 558.5, reflecting strong buying interest.<BR><BR>Moreover, Nephrocare Health is trading above its moving averages across various time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bullish trend. However, it is worth noting that there has been a decline in investor participation, with delivery volume falling by 37.11% against the 5-day average, which could suggest a potential concern for sustained momentum. Despite this, the stock remains liquid enough for trading, supporting its current upward movement. Overall, the combination of positive performance metrics and recent gains contributes to the rise in Nephrocare Health Services Ltd's stock price.

View full answer

Why is Nephrocare Health Services Ltd falling/rising?

10-Apr-2026

As of 09-Apr, Nephrocare Health Services Ltd's stock price is rising to 549.10, reflecting a 0.48% increase. This upward trend is supported by consistent gains over the past three days, increased investor participation, and trading above key moving averages, despite a slight underperformance relative to its sector.

As of 09-Apr, Nephrocare Health Services Ltd's stock price is rising, currently at 549.10, with a change of 2.6 (0.48%) upward. This increase can be attributed to several factors. The stock has been gaining consistently over the last three days, with a total return of 4.48% during this period. Additionally, Nephrocare is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend in its price movement.<BR><BR>Investor participation has also increased, as evidenced by a significant rise in delivery volume, which was 81.88k on April 8, reflecting a 221.45% increase compared to the 5-day average. This heightened activity suggests growing interest and confidence among investors in the stock. However, it is worth noting that while the stock has performed well recently, it underperformed its sector by 0.39% today. Despite this, the overall upward momentum and increased trading activity contribute to the stock's rising price.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Healthcare Services

stock-summary
Market cap

INR 5,493 Cr (Small Cap)

stock-summary
P/E

82.00

stock-summary
Industry P/E

57

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.02

stock-summary
Return on Equity

11.74%

stock-summary
Price to Book

9.57

Revenue and Profits:
Net Sales:
260 Cr
(Quarterly Results - Dec 2025)
Net Profit:
32 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
11.14%
0%
11.14%
6 Months
0%
0%
0.0%
1 Year
0%
0%
0.0%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Nephrocare Healt for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Announcement under Regulation 30 (LODR)-Change in Management

03-Apr-2026 | Source : BSE

Designation of Mr. Prashant Vinodkumar Goenka Chief Financial Officer as the Chief Risk Officer of the company w.e.f. April 03 2026 in addition to his existing responsibilities as per SEBI Listing Regulations.

Announcement Under Regulation 30 (LODR)- Disclosure Of Litigation Filed By The Company

02-Apr-2026 | Source : BSE

Pursuant to Regulation 30 of SEBI LODR 2015 this is to inform that the Company has filed a Writ Petition on April 02 2026 before Honble High Court of Jammu & Kashmir and Ladakh at Srinagar.

Closure of Trading Window

25-Mar-2026 | Source : BSE

Trading window shall be closed till 48 hours from the declaration of Audited Financial Results of the company for the quarter and year ended March 31 2026.

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
4.52
Debt to EBITDA (avg)
4.40
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.83
Tax Ratio
23.26%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
17.40%
ROCE (avg)
4.47%
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
82
Industry P/E
57
Price to Book Value
9.64
EV to EBIT
58.41
EV to EBITDA
33.01
EV to Capital Employed
9.78
EV to Sales
7.28
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
16.74%
ROE (Latest)
11.74%

Technicals key factors

Indicator
Weekly
Monthly
MACD
RSI
No Signal
Bollinger Bands
KST
Dow Theory
Mildly Bullish
OBV
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 7 Schemes (3.1%)

FIIs

Held by 20 FIIs (9.3%)

Promoter with highest holding

Edoras Investment Holdings Pte Ltd (28.3%)

Highest Public shareholder

Investcorp India Investments Holding Limited (6.29%)

Individual Investors Holdings

5.92%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 3.04% vs 12.81% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 126.07% vs -499.14% in Sep 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "160.66",
          "val2": "155.92",
          "chgp": "3.04%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "22.86",
          "val2": "23.47",
          "chgp": "-2.60%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "3.96",
          "val2": "41.05",
          "chgp": "-90.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "8.45",
          "val2": "-32.41",
          "chgp": "126.07%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "14.23%",
          "val2": "15.05%",
          "chgp": "-0.82%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Nephrocare Healt"
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Nephrocare Healt"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "543.60",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "94.89",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "14.30",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "34.24",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "17.46%",
          "val2": "NA%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Dec'25 - QoQstock-summary

Dec'25
Sep'25
Change(%)
Net Sales
160.66
155.92
3.04%
Operating Profit (PBDIT) excl Other Income
22.86
23.47
-2.60%
Interest
3.96
41.05
-90.35%
Exceptional Items
0.00
0.00
Standalone Net Profit
8.45
-32.41
126.07%
Operating Profit Margin (Excl OI)
14.23%
15.05%
-0.82%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2025 is 3.04% vs 12.81% in Sep 2025

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Dec 2025 is 126.07% vs -499.14% in Sep 2025

Annual Results Snapshot (Standalone) - Mar'25stock-summary

Mar'25
Change(%)
Net Sales
543.60
NA
NA
Operating Profit (PBDIT) excl Other Income
94.89
NA
NA
Interest
14.30
NA
NA
Exceptional Items
0.00
NA
NA
Standalone Net Profit
34.24
NA
NA
Operating Profit Margin (Excl OI)
17.46%
NA%
NA
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

stock-summaryCompany CV
About Nephrocare Health Services Ltd stock-summary
stock-summary
Nephrocare Health Services Ltd
Small Cap
Healthcare Services
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available